Despite the huge advances we have witnessed in recent years, one of the biggest barriers to technology-driven decentralized clinical trial adoption remains a lack of agreed standards for compliance and ethics.
There is ample opportunity for those who can overcome staffing issues and employee burnout to take advantage of the countless new studies waiting for clinical research sites that are adequately prepared to handle them.
Efforts to improve the regulatory review process through standardization, harmonization, and digitalization have gathered steam in recent years with regulators and industry alike pushing forward with data-driven initiatives.
Central to the discussion of assuring access to safe and effective therapeutics and devices is the recruitment of study participants who represent those destined to use these products.
What must life sciences company leaders do to make sure their staff are engaged? While there are many aspects to be considered, one that takes this goal a long way is having an effective training program.